NIH expects to rule on ritonavir march-in petition "by the end of the year"

Mark Rohrbaugh has written to Krista Cox to acknowledge the October 25, 2012 march-in petition. According to Rohrbaugh, the petition has be delegated to NIH's Office of Technology Transfer (OTT), and "NIH has begun to review the issues you have brought to our attention." Rohrbaugh closes by saying "We expect to respond to your request by the end of the year."

AttachmentSize
WF_316058_March-In_Request_Ritonavir.pdf126.02 KB